Goodwin Procter advised Synaffix on the deal. Synaffix announced a licensing agreement with Amgen to develop next generation of antibody-drug conjugates (ADCs) using Synaffix technology. Under the...
Synaffix’s Licensing Agreement with Amgen
STALICLA’s In-Licensing Agreement with Novartis
Goodwin Procter advised STALICLA SA on the deal. STALICLA SA announced its exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder, neurodevelopmental...
QuadReal’s Stake Acquisition in Precede Capital Partners
Kirkland & Ellis advised QuadReal Property Group, and Goodwin Procter advised TowerBrook Capital Partners on the deal. QuadReal Property is investing in UK real estate development...
Goldman Sachs and Everstone’s Acquisition of Cprime
Goodwin Procter advised Goldman Sachs Asset Management and Everstone Capital Partners on the deal. Goldman Sachs Asset Management and Everstone Capital Partners announced the acquisition of Cprime....
Royalty Pharma’s Acquisition of Royalty Interest in SPINRAZA and Pelacarsen from Ionis
Fenwick and Goodwin represented Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry,...
Pinova Capital’s Acquisition of Majority Stake in VTI Ventil Technik GmbH
CMS and Goodwin advised Pinova on the deal. Funds advised by independent private equity firm Pinova Capital GmbH have acquired a majority stake in VTI Ventil...
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
Equistone’s Acquisition of BUKO Infrasupport and BUKO Waakt
Equistone was advised on the transaction by PwC (financial, tax, IT, debt advisory), DC Advisory (M&A), Roland Berger and Munich Strategy (Commercial), Vesper, Clifford Chance (Legal)...
Merck’s License and Collaboration Agreement with Kelun-Biotech
Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
Alvarium Investments’ $1.4 Billion Business Combination with Tiedemann Group and Cartesian Growth Corporation
Goodwin Procter and Appleby advised Alvarium Investments on the deal. Seward & Kissel represented Tiedemann Advisors and TIG Advisors. Homburger advised Tiedemann Group and its Switzerland-based...
UMIAMI’s Acquisition of a Production Plant in Duppigheim
Goodwin advised UMIAMI on the deal. UMIAMI, a French foodtech startup specializing in 100% plant-based poultry fillets, announced the acquisition of a real estate asset of 14...
GFP Real Estate, Metro Loft Management and Rockwood Capital’s Financing and Redevelopment of 25 Water Street, New York
Fried Frank acted as counsel to GFP Real Estate and Metro Loft Management in the transaction while Goodwin represented Rockwood Capital. GFP Real Estate and Metro...